Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Reference Intervals for Clinical Chemistry Analytes for Transgender Men and Women on Stable Hormone Therapy.

Publication ,  Journal Article
Humble, RM; Greene, DN; Schmidt, RL; Winston McPherson, G; Rongitsch, J; Imborek, KL; Nisly, N; Dole, NJ; Dane, SK; Frerichs, J; Krasowski, MD
Published in: J Appl Lab Med
September 1, 2022

BACKGROUND: Gender-affirming hormone therapy with either estradiol or testosterone is commonly prescribed for transgender individuals. Masculinizing or feminizing hormone therapy may impact clinical chemistry analytes, but there is currently a lack of published reference intervals for the transgender population. METHODS: Healthy transgender and nonbinary individuals who had been prescribed either estradiol (n = 93) or testosterone (n = 82) for at least 12 months were recruited from primary care and internal medicine clinics specializing in transgender medical care. Electrolytes, creatinine, urea nitrogen, enzymes (alkaline phosphatase, ALK; alanine aminotransferase, ALT; aspartate aminotransferase, AST; gamma-glutamyltransferase, GGT), hemoglobin A1c, lipids [total cholesterol, high-density lipoprotein (HDL), triglycerides], and high-sensitivity C-reactive protein (hsCRP) were measured on 2 clinical chemistry platforms. Reference intervals (central 95%) were calculated according to Clinical Laboratory Standards Institute guidelines. RESULTS: There was minimal impact of gender-affirming hormone therapy on electrolytes, urea nitrogen, hemoglobin A1c, and hsCRP. In general, the enzymes studied shifted toward affirmed gender. Creatinine values for both transgender cohorts overlaid the reference interval for cisgender men, with no shift toward affirmed gender for the estradiol cohort. The effects on lipids were complex, but with a clear shift to lower HDL values in the testosterone cohort relative to cisgender women. CONCLUSIONS: Transgender individuals receiving either masculinizing or feminizing hormone therapy showed significant changes in some analytes that have sex-specific variation in the cisgender population. The clearest shifts toward affirmed gender were seen with enzymes for the estradiol and testosterone cohorts and with creatinine and HDL in the testosterone cohort.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Appl Lab Med

DOI

ISSN

2576-9456

Publication Date

September 1, 2022

Volume

7

Issue

5

Start / End Page

1131 / 1144

Location

England

Related Subject Headings

  • Urea
  • Transgender Persons
  • Testosterone
  • Nitrogen
  • Male
  • Lipids
  • Humans
  • Glycated Hemoglobin
  • Female
  • Estradiol
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Humble, R. M., Greene, D. N., Schmidt, R. L., Winston McPherson, G., Rongitsch, J., Imborek, K. L., … Krasowski, M. D. (2022). Reference Intervals for Clinical Chemistry Analytes for Transgender Men and Women on Stable Hormone Therapy. J Appl Lab Med, 7(5), 1131–1144. https://doi.org/10.1093/jalm/jfac025
Humble, Robert M., Dina N. Greene, Robert L. Schmidt, Gabrielle Winston McPherson, Jessica Rongitsch, Katherine L. Imborek, Nicole Nisly, et al. “Reference Intervals for Clinical Chemistry Analytes for Transgender Men and Women on Stable Hormone Therapy.J Appl Lab Med 7, no. 5 (September 1, 2022): 1131–44. https://doi.org/10.1093/jalm/jfac025.
Humble RM, Greene DN, Schmidt RL, Winston McPherson G, Rongitsch J, Imborek KL, et al. Reference Intervals for Clinical Chemistry Analytes for Transgender Men and Women on Stable Hormone Therapy. J Appl Lab Med. 2022 Sep 1;7(5):1131–44.
Humble, Robert M., et al. “Reference Intervals for Clinical Chemistry Analytes for Transgender Men and Women on Stable Hormone Therapy.J Appl Lab Med, vol. 7, no. 5, Sept. 2022, pp. 1131–44. Pubmed, doi:10.1093/jalm/jfac025.
Humble RM, Greene DN, Schmidt RL, Winston McPherson G, Rongitsch J, Imborek KL, Nisly N, Dole NJ, Dane SK, Frerichs J, Krasowski MD. Reference Intervals for Clinical Chemistry Analytes for Transgender Men and Women on Stable Hormone Therapy. J Appl Lab Med. 2022 Sep 1;7(5):1131–1144.

Published In

J Appl Lab Med

DOI

ISSN

2576-9456

Publication Date

September 1, 2022

Volume

7

Issue

5

Start / End Page

1131 / 1144

Location

England

Related Subject Headings

  • Urea
  • Transgender Persons
  • Testosterone
  • Nitrogen
  • Male
  • Lipids
  • Humans
  • Glycated Hemoglobin
  • Female
  • Estradiol